STOCK TITAN
  1. Home
  2. News
  3. ATR

Aptargroup Inc. - ATR STOCK NEWS

Welcome to our dedicated news page for Aptargroup (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aptargroup's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aptargroup's position in the market.

News
Aptar Declares Quarterly Dividend
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces a quarterly cash dividend of $0.41 per share and a conference call to discuss first quarter results for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
dividends
-
News
Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been recognized for its emissions reductions efforts and named to the CDP Supplier Engagement Leaderboard for the fourth consecutive year. Aptar received an 'A' supplier engagement rating, surpassing the global and sector averages. The company collaborates with suppliers to reduce emissions and promote sustainability, with a focus on environmentally conscious supply chain practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
News
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year, ranking 29th for 2024. The company's commitment to sustainability is evident through various achievements and recognitions, including a Platinum level rating from EcoVadis, significant progress in emissions reduction, and eco-design initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
News
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions
Rhea-AI Summary
Aptar Digital Health, a part of AptarGroup, Inc., has entered into an enterprise agreement with Biogen Inc. to develop digital health solutions for neurological and rare diseases globally. The collaboration will cover several indications in neurology and immunology across 15 countries, focusing on providing advanced digital solutions for disease management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
none
-
News
Aptar Reports Fourth Quarter and Annual 2023 Results
Rhea-AI Summary
AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter operational results, with a 5% increase in sales and a 6% increase in net income. The company achieved double-digit growth in its proprietary drug delivery systems and fragrance dispensing technologies. The Pharma segment had an exceptional year with over 20% core sales growth in the fourth quarter, while the beauty dispensing solutions in fragrance also delivered double-digit core sales growth for 2023. The company's focus on cost management and operational leverage yielded margin expansion for each segment compared to the prior year. Tanda, President and CEO, expressed optimism for continued solid growth in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
none
-
News
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive Year
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year, ranking number 29 out of 600 U.S. companies and first in its industry category. The company's focus on sustainability, renewable energy, and innovative, sustainable products has earned it recognition by Forbes and 3BL Media as well. Aptar publishes an annual Sustainability Report and GRI Index to record and highlight its sustainability efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
none
News
Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.41 per share, with a payment date of February 22, 2024. The company will hold a conference call on February 9, 2024, to discuss its fourth quarter and year-end results for 2023. Additionally, the 2024 Annual Meeting of Stockholders will be held virtually on May 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
dividends
-
News
Aptar to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) to participate in the 42nd Annual J.P. Morgan Healthcare Conference. Stephan Tanda, President and CEO, to present at 1:30 p.m. Eastern Standard Time. Bob Kuhn, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available. Presentation will be available on the Investors page at www.aptar.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
conferences
-
News
Aptar Announces 2024 Quarterly Conference Call Dates
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces dates and times of quarterly conference calls for 2024, including 4th Quarter and Annual 2023 Results on February 8, 2024, 1st Quarter 2024 Results on April 25, 2024, 2nd Quarter 2024 Results on July 25, 2024, and 3rd Quarter 2024 Results on October 24, 2024. Press releases will be issued after the close of trading on the NYSE, with conference calls lasting approximately one hour and available for replay on investors.aptar.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
none
News
Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces a contract with the FDA to study low Global Warming Potential propellant metered dose inhalers, supporting ongoing FDA efforts to provide guidance on the regulatory framework. The contracted work is valued at up to approximately $6 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none
Stock ATR logo
Aptargroup Inc.

NYSE:ATR

ATR Rankings

#823 Ranked by Market Cap
#847 Ranked by Stock Gains
#1750 Ranked by Dividends

ATR Stock Data

9.17B
65.52M
0.51%
91.82%
0.45%
Metal Can Manufacturing
Manufacturing
Link
US
Crystal Lake

About ATR

aptar is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets. aptar is headquartered in crystal lake, illinois, with manufacturing facilities in north america, europe, asia and south america. for more information, visit www.aptar.com.